HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics ; volume:7 ; number:1 ; day:6 ; month:2 ; year:2019 ; pages:1-16 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (6.2.2019), 1-16, 12.2019

Creator: Laino, Andressa S.
Betts, B. C.
Veerapathran, A.
Dolgalev, I.
Sarnaik, A.
Quayle, S. N.
Jones, S. S.
Weber, J. S.
Woods, David M.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40425-019-0517-0

URN: urn:nbn:de:101:1-2019031123330213104649

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Laino, Andressa S.
Betts, B. C.
Veerapathran, A.
Dolgalev, I.
Sarnaik, A.
Quayle, S. N.
Jones, S. S.
Weber, J. S.
Woods, David M.
SpringerLink (Online service)

Other Objects (12)

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Hochschulschrift

Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Selektive HDAC6-Inhibitoren: Synthese und biologische Testung

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Hochschulschrift

Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Selektive HDAC6-Inhibitoren: Synthese und biologische Testung

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Hochschulschrift

Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Selektive HDAC6-Inhibitoren: Synthese und biologische Testung

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Selektive HDAC6-Inhibitoren: Synthese und biologische Testung

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Selektive HDAC6-Inhibitoren: Synthese und biologische Testung

Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Selektive HDAC6-Inhibitoren: Synthese und biologische Testung

Related objects

Reset password